Back to Search
Start Over
Ebola vaccine regimen generates strong immune response in children and adults in a clinical trial in Sierra Leone
- Source :
- Legal Monitor Worldwide. September 15, 2021
- Publication Year :
- 2021
-
Abstract
- Johnson & Johnsons two-dose Ebola vaccine regimen is safe, well tolerated and produces a strong immune response in people over the age of one, according to two new papers published [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Legal Monitor Worldwide
- Publication Type :
- News
- Accession number :
- edsgcl.675476332